Shopping Cart
- Remove All
- Your shopping cart is currently empty
GNE-0723 is a selective positive allosteric modulator of the NMDA receptor, with an EC50 of 21 nM for GluN2A. It can cross the blood-brain barrier (BBB) and improve outcomes in Dravet syndrome (DS) and Alzheimer's disease (AD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $457 | In Stock | |
5 mg | $1,060 | In Stock | |
10 mg | $1,420 | In Stock | |
25 mg | $2,120 | In Stock | |
50 mg | $2,780 | In Stock |
Description | GNE-0723 is a selective positive allosteric modulator of the NMDA receptor, with an EC50 of 21 nM for GluN2A. It can cross the blood-brain barrier (BBB) and improve outcomes in Dravet syndrome (DS) and Alzheimer's disease (AD). |
Targets&IC50 | GluN2C:7.4 μM(EC50), GluN2D:6.2 μM(EC50), GluN2A:21 nM (EC50) |
In vitro | GNE-0723 is a brain-permeable NMDAR positive allosteric modulator with EC50 of 21 nM/7.4μM/6.2 μM for GluN2A/2C/2D. [1] |
Synonyms | GNE0723 |
Molecular Weight | 467.78 |
Formula | C16H8ClF6N5OS |
Cas No. | 1883518-31-7 |
Smiles | C(F)(F)(F)C1=C(N2C(S1)=NC(CN3N=C(C(F)(F)F)C=C3Cl)=CC2=O)[C@H]4[C@H](C#N)C4 |
Relative Density. | 1.84 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 160 mg/mL (342.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.